I am a student in a combined degree program for both an MD and a PhD. My research specialties are pharmacology and immunology. I am interested in drug, diagnostic and device development. I am also interested in business development, strategic planning, investing and finance.
Ray 69 worked as a supplier of marketing goodies to the international pharma industry for his whole working life. Retired wealthy by taking candy from the dummies that populate the industry. Even now while they proclaim to know the big pharma model is bust they still haven't got the guts to make the radical jump into the new world
Just an average investor... primarily in American equity and bonds.
(Important Note: My articles, blogs, comments, reference links and messages are not intended to be investment advisements; or to value securities. Examples and considerations are hypothetical and educational. Please consult a financial advisor before making investments in any security. Thank you for reading!)
Hereby I declare that the views expressed in my posts are those of Alp Bugra Basat and do not necessarily reflect the views of my industry partners, research supervisors-collaborators and companies I have invested in.
I like basic science; if it is translated into new treatments. I like the biotechs with cutting-edge science. I don't like PI3K, ras, akt inhibitors. I like antibody-drug conjugates. I like sirtuin. I may not believe in β-amyloid. I really like ivacaftor. I am crazy about talimogene laherparepvec. I love the drugs like eteplirsen.
In addition, I don't fall in love with stocks, it means that my opinions expressed here can change in a milisecond, after I get more info.
A special thank goes to Osman Murat Bastopcu!